Health stocks lagged Thursday but fared better than the broader market, with the Nasdaq and Amex biotechnology indices down 1.6% and 1.7%, respectively.

Among individual stocks, notable movers were:

Simcere ( SCR), up 15.7% at $7.61

Osiris ( OSIR), up 9.5% at $17.01

Salix ( SLXP), up 9.2% at $9.93

Allos Therapeutics ( ALTH), up 7.6% at $8.46

Medivation ( MDVN), down 14.4% at $15.86

Enzon ( ENZN), down 10.9% at $4.30

Amgen ( AMGN), down 6.8% at $37.45

Amylin ( AMLN), down 8.5% at $8.21

Sanofi-Aventis ( SNY), down 4.6% at $28.34
This article was written by a staff member of TheStreet.com.

If you liked this article you might like

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Akorn Rises on Deal Talk

Medivation Founder Takes Helm at Axovant, Shares Spike

Second-Quarter Picks and Pans

How I'd Play Biotech Buyout Rumors

How I'd Play Biotech Buyout Rumors